Key result
PPARGC1A -3974 C allele is linked to ~40% lower risk of multiple minimal carotid lesions.
Why the study?
Do PPARGC1A polymorphisms associate with asymptomatic carotid atherosclerosis in high-risk middle-aged subjects?
Observational (n=1,379)
Do PPARGC1A polymorphisms associate with asymptomatic carotid atherosclerosis in high-risk middle-aged subjects?
Odds Ratio: 0.6
p-value: p=0.007
The PPARGC1A -3974 C allele is associated with a decreased risk of carotid plaques, suggesting a potential role for PGC-1alpha in atherogenic pathways.
Should not change practice; hypothesis-generating for PPARGC1A in carotid plaque burden, needs prospective confirmation.
BACKGROUND AND PURPOSE: Peroxisome proliferator activated receptor gamma coactivator 1alpha (PGC-1alpha, PPARGC1A) integrates the transcriptional program of mitochondrial biogenesis. Mitochondria are the main source of cellular reactive oxygen species implicated in atherogenesis. We therefore ascertained associations of PPARGC1A polymorphisms with asymptomatic carotid atherosclerosis. METHODS: Eight single nucleotide polymorphisms tagging two haplotype blocks within PPARGC1A were studied in 1379 participants of the Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk. Early atherosclerosis was assessed by intima-media thickness and extent of plaques (B-score) of the carotid arteries. RESULTS: No associations of carotid artery intima-media thickness measurements with block 1 or 2 haplotype distributions or individual haplotypes were observed. However, the block 1 haplotype carrying the variant C nucleotide at -3974 relative to the transcription start site was associated with disease status defined by the presence of more than one minimal lesion and the -3974 C allele was associated with decreased risk (odds ratio=0.60, P=0.007) after adjustment for linkage disequilibrium between single nucleotide polymorphisms. CONCLUSIONS: These result are consistent with the concept that risk factors for distinct carotid phenotypes may vary and suggest, but do not prove, that PGC-1alpha may contribute to the regulation of atherogenic pathways.
No takes yet. Share an insight, caveat, or question.
Iglseder et al. (2006) conducted an observational in Asymptomatic carotid atherosclerosis (n=1,379). PPARGC1A -3974 C allele vs. Non-carriers was evaluated on Disease status defined by the presence of more than one minimal lesion (OR 0.60, p=0.007). The PPARGC1A -3974 C allele was associated with a decreased risk of having more than one minimal carotid lesion (OR 0.60, P=0.007), but not with carotid intima-media thickness.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: